Amdocs Limited (NASDAQ:DOX – Get Free Report) declared a quarterly dividend on Tuesday, November 3rd. Shareholders of record on Thursday, December 31st will be given a dividend of $0.5690 per share by the technology company on Friday, January 29th. This represents a $2.28 annualized dividend and a yield of 5.2%. The ex-dividend date of this dividend is Thursday, December 31st.
Amdocs has increased its dividend payment by an average of 0.1% annually over the last three years and has increased its dividend every year for the last 14 years. Amdocs has a payout ratio of 29.9% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Amdocs to earn $8.06 per share next year, which means the company should continue to be able to cover its $2.27 annual dividend with an expected future payout ratio of 28.2%.
Amdocs Stock Down 30.1%
NASDAQ DOX opened at $43.66 on Thursday. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23. The stock’s 50 day moving average is $60.27 and its 200 day moving average is $62.38. Amdocs has a 12 month low of $41.44 and a 12 month high of $85.63. The stock has a market cap of $4.71 billion, a PE ratio of 9.35, a P/E/G ratio of 1.00 and a beta of 0.42.
Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, meeting the consensus estimate of $1.98. The business had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.19 billion. Amdocs had a return on equity of 20.70% and a net margin of 10.59%. The firm’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.83 EPS. Research analysts predict that Amdocs will post 7.12 EPS for the current fiscal year.
More Amdocs News
Here are the key news stories impacting Amdocs this week:
- Positive Sentiment: Amdocs announced an expanded, eight-year strategic agreement with AT&T, which could support future business, and agreed to acquire insurance software company EIS for $340 million as it seeks growth beyond telecom. AT&T and Amdocs Expand Collaboration Amdocs acquires insurance tech firm EIS for $340 million
- Positive Sentiment: The company declared a quarterly dividend of $0.569 per share, equivalent to $2.28 annualized.
- Negative Sentiment: The central concern is an escalating contractual dispute with T-Mobile, which may put the relationship—and associated revenue—at risk. Amdocs’ fiscal 2027 outlook anticipates a 7–11% pro forma revenue decline and an operating margin of 19.2–19.8%; reports also note the outlook allows for a possible end to its T-Mobile agreements. Amdocs Stock Has Its Worst Day in 24 Years as T-Mobile Business Is at Risk
- Negative Sentiment: Investors are also weighing weaker forward indicators: backlog reportedly fell nearly 10% to $3.5 billion, and uncertainty over T-Mobile’s revenue contribution makes it harder to assess how much of the forecast decline could be offset by other customers. Amdocs: The T-Mobile Shock Changes Everything
- Negative Sentiment: Several law firms have announced investigations into potential securities-law violations, focusing on whether Amdocs adequately disclosed risks related to its T-Mobile relationship. These are allegations and investigations, not findings of wrongdoing, but add uncertainty for investors. Amdocs securities fraud investigation notice
Amdocs Company Profile
Amdocs Ltd. (NASDAQ: DOX) is a global provider of software and technology services for communications, media and entertainment companies. Its solutions help service providers manage customer relationships, billing, subscriptions, product offerings and digital experiences across consumer and enterprise markets.
The company’s portfolio includes business support systems and operational support systems, cloud-based software, artificial intelligence and automation tools, network and service management platforms, and solutions for media distribution and monetization.
Read More
- Five stocks we like better than Amdocs
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
